TUR vs. SBIO
TUR (iShares MSCI Turkey ETF) and SBIO (ALPS Medical Breakthroughs ETF) are both exchange-traded funds - TUR is a Emerging Markets Equities fund tracking the MSCI Turkey Investable Market Index, while SBIO is a Health & Biotech Equities fund tracking the S-Network Medical Breakthroughs Index. Both are passively managed. Over the past 10 years, TUR returned 2.67%/yr vs 8.36%/yr for SBIO. At a 0.18 correlation, their price movements are largely independent. TUR charges 0.59%/yr vs 0.50%/yr for SBIO.
Performance
TUR vs. SBIO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, TUR achieves a 12.06% return, which is significantly higher than SBIO's -1.72% return. Over the past 10 years, TUR has underperformed SBIO with an annualized return of 2.67%, while SBIO has yielded a comparatively higher 8.36% annualized return.
TUR
- 1D
- 1.26%
- 1M
- -11.46%
- YTD
- 12.06%
- 6M
- 13.21%
- 1Y
- 25.17%
- 3Y*
- 10.28%
- 5Y*
- 13.98%
- 10Y*
- 2.67%
SBIO
- 1D
- -0.36%
- 1M
- -9.33%
- YTD
- -1.72%
- 6M
- -2.48%
- 1Y
- 59.38%
- 3Y*
- 16.69%
- 5Y*
- 1.33%
- 10Y*
- 8.36%
TUR vs. SBIO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
TUR iShares MSCI Turkey ETF | 12.06% | -1.54% | 12.91% | -8.83% | 105.75% | -27.41% | -1.19% | 14.49% | -41.46% | 37.58% |
SBIO ALPS Medical Breakthroughs ETF | -1.72% | 55.07% | 3.81% | 8.68% | -28.08% | -17.55% | 21.17% | 50.30% | -11.81% | 45.67% |
Correlation
The correlation between TUR and SBIO is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.09 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.14 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.15 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.18 |
Correlation (All Time) Calculated using the full available price history since Dec 31, 2014 | 0.18 |
TUR vs. SBIO - Sectors Allocation Comparison
Sectors
TUR
SBIO
Industrials
-
Financial Services
Consumer Defensive
-
Basic Materials
-
Consumer Cyclical
-
Energy
-
Real Estate
-
Utilities
-
Communication Services
-
Healthcare
Technology
-
Industrials
TUR
SBIO
-
Financial Services
TUR
SBIO
Consumer Defensive
TUR
SBIO
-
Basic Materials
TUR
SBIO
-
Consumer Cyclical
TUR
SBIO
-
Energy
TUR
SBIO
-
Real Estate
TUR
SBIO
-
Utilities
TUR
SBIO
-
Communication Services
TUR
SBIO
-
Healthcare
TUR
SBIO
Technology
TUR
SBIO
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TUR vs. SBIO — Risk / Return Rank
TUR
SBIO
TUR vs. SBIO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares MSCI Turkey ETF (TUR) and ALPS Medical Breakthroughs ETF (SBIO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| TUR | SBIO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.02 | ||
| Sortino ratioReturn per unit of downside risk | -1.31 | ||
| Omega ratioGain probability vs. loss probability | 1.20 | 1.33 | -0.13 |
| Calmar ratioReturn relative to maximum drawdown | 1.57 | 4.72 | -3.14 |
| Martin ratioReturn relative to average drawdown | 4.58 | 13.54 | -8.96 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| TUR | SBIO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.99 | 2.02 | -1.02 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.41 | 0.04 | +0.37 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.08 | 0.25 | -0.18 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.03 | 0.21 | -0.18 |
Drawdowns
TUR vs. SBIO - Drawdown Comparison
The maximum TUR drawdown since its inception was -72.34%, which is greater than SBIO's maximum drawdown of -63.06%. Use the drawdown chart below to compare losses from any high point for TUR and SBIO.
Loading charts...
Drawdown Indicators
| TUR | SBIO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -72.34% | -63.06% | -9.28% |
Max Drawdown (1Y)Largest decline over 1 year | -16.07% | -12.66% | -3.41% |
Max Drawdown (3Y)Largest decline over 3 years | -31.63% | -42.44% | +10.81% |
Max Drawdown (5Y)Largest decline over 5 years | -31.63% | -53.10% | +21.47% |
Max Drawdown (10Y)Largest decline over 10 years | -59.25% | -63.06% | +3.81% |
Current DrawdownCurrent decline from peak | -29.48% | -17.90% | -11.58% |
Average DrawdownAverage peak-to-trough decline | -39.89% | -28.43% | -11.46% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.51% | 4.40% | +1.11% |
Volatility
TUR vs. SBIO - Volatility Comparison
iShares MSCI Turkey ETF (TUR) has a higher volatility of 14.02% compared to ALPS Medical Breakthroughs ETF (SBIO) at 9.87%. This indicates that TUR's price experiences larger fluctuations and is considered to be riskier than SBIO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| TUR | SBIO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 14.02% | 9.87% | +4.15% |
Volatility (6M)Calculated over the trailing 6-month period | 20.10% | 22.68% | -2.58% |
Volatility (1Y)Calculated over the trailing 1-year period | 25.46% | 29.62% | -4.16% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 34.18% | 33.56% | +0.62% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 34.41% | 33.18% | +1.23% |
TUR vs. SBIO - Expense Ratio Comparison
TUR has a 0.59% expense ratio, which is higher than SBIO's 0.50% expense ratio.
Dividends
TUR vs. SBIO - Dividend Comparison
TUR's dividend yield for the trailing twelve months is around 2.14%, while SBIO has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SBIO ALPS Medical Breakthroughs ETF | 0.00% | 0.00% | 3.55% | 0.22% | 0.00% | 0.00% | 0.00% | 0.04% | 2.79% | 1.77% | 0.00% | 0.00% |
TUR iShares MSCI Turkey ETF | 2.14% | 2.40% | 1.79% | 4.43% | 1.97% | 4.22% | 0.87% | 3.29% | 4.05% | 2.64% | 2.89% | 3.04% |
Frequently Asked Questions
TUR and SBIO have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
TUR has higher volatility (14.02%) compared to SBIO (9.87%). In terms of maximum drawdown, TUR dropped -72.34% vs SBIO's -63.06%.
On 10-year performance, SBIO leads with 8.36% vs 2.67% for TUR. On fees, SBIO is cheaper at 0.50% per year. On volatility, SBIO has been the lower-risk option at 9.87%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, SBIO has performed better with a 8.36% return vs 2.67%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
SBIO is cheaper with a 0.50% expense ratio, compared with 0.59% for TUR.
TUR has the higher dividend yield at 2.14%, compared with 0.00% for SBIO.
TUR is categorized as Emerging Markets Equities, while SBIO is Health & Biotech Equities. TUR tracks MSCI Turkey Investable Market Index, while SBIO tracks S-Network Medical Breakthroughs Index. They also come from different issuers: iShares and SS&C. Their fees differ too: 0.59% for TUR and 0.50% for SBIO.
SBIO currently has the higher Sharpe Ratio (2.02 vs 0.99), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for TUR and SBIO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer